Granules Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GRANULES, and what generic and branded alternatives to GRANULES drugs are available?
GRANULES has fifty-nine approved drugs.
There is one tentative approval on GRANULES drugs.
Summary for Granules
US Patents: | 0 |
Tradenames: | 46 |
Ingredients: | 46 |
NDAs: | 59 |
Patent Litigation for Granules: | See patent lawsuits for Granules |
Drugs and US Patents for Granules
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Granules | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 217027-006 | Jan 23, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Granules | POTASSIUM CHLORIDE | potassium chloride | SOLUTION;ORAL | 213392-002 | Jan 29, 2021 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Granules | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209313-002 | Mar 16, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.